Flyer

Annals of Clinical and Laboratory Research

  • ISSN: 2386-5180
  • Journal h-index: 19
  • Journal CiteScore: 5.42
  • Journal Impact Factor: 4.64
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
+44 7460731551
Awards Nomination
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Directory of Research Journal Indexing (DRJI)
  • Publons
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • Zenodo
Share This Page

Abstract

Haematological Indices of HIV Seropositive Subjects at Nnamdi Azikiwe University Teaching Hospital (Nauth), Nnewi

Obiomah Chinwe Favour, Obeagu Emmanue Ifeanyi, Ochei Kingsley Chinedum, Swem Collins Abum and Amachukwu Blessing Ozioma

This study was carried out to provide information on the haematologic indices of HIV Patients on ART and those not on ART. Blood sample was collected from 160 subjects, 55 HIV-infected patients on antiretroviral therapy (ART), 55 HIV-infected patients not on ART and 50 apparently healthy HIV Sero-negative individuals as controls. Platelet (PLT), Total white blood cell Count (TWBC), Lymphocyte Count (LYMPH), Neutrophil Count (NEUT), Haemoglobin (HGB), Red Blood Cell Count (RBC), Mean Cell Volume (MCV), Mean cell Haemoglobin (MCH), Mean Cell Haemoglobin Concentration (MCHC), Red Cell Distribution Width (RDW), Platelet Distribution Width (PDW), Mean Platelet Volume (MPV) and Retroviral screening (RVS) of the subjects were determined using standard methods after obtaining ethics approval and informed consent of the subjects. ANOVA and t-test were used for statistical analysis. HGB, RBC and MCHC were significantly lower in HIV patients (F=60.57; 19.26; 12.83; 9.84; P<0.05 respectively) compared with control subjects. HCT, HGB, MCV, MCH and RDW of HIV patients on ART were significantly higher (t=2.96; 3.04; 6.30; 5.10; P<0.05 respectively) compared with HIV patients not on ART.